US healthcare spending soars to over $5 trillion in 2024

Reuters
01/15
US healthcare spending soars to over $5 trillion in 2024

By Amina Niasse

NEW YORK, Jan 14 (Reuters) - U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion in 2023, driven by increased health insurance enrollment and a jump in use of medical services, particularly in private health insurance plans, the U.S. Centers for Medicare & Medicaid Services said on Wednesday.

CMS said healthcare spending accounted for 18% of U.S. gross domestic product in 2024, up from 17.7% in 2023 and outpacing U.S. economic growth. The agency oversees Medicare plans for people aged 65 and older or with disabilities, and Medicaid for low-income Americans.

Spending on government administration including services involving Medicaid and Medicare, had the biggest increase, rising 14.7% in 2024 from a 7.8% increase a year earlier.

The agency said changes in Medicaid coverage after COVID-era policies lapsed were a big contributor to the higher administrative costs, with Medicaid government administration costs alone increasing 19.8% in 2024 after a 9.2% rise in 2023.

Spending on services provided by non-medical or dental professionals and home healthcare followed, with increases of 10.8% and 10.2%, respectively.

CMS said hospital pricing also contributed to elevated spending in 2024, increasing 3.4%, the highest rate since 2007. Spending on hospital care services totaled $1.6 trillion, rising 8.9%, a deceleration in growth from 10.6% in 2023.

Affordable Care Act enrollment in 2024 increased over 30% to 21.1 million people from 16.2 million in 2023. Overall private health insurance enrollment, which includes Obamacare plans, increased 3.5% in 2024 to 214.3 million people covered from 207 million in 2023.

A 2024 special enrollment period that allowed people who had been kicked off Medicaid to enroll in ACA plans also contributed to increases in Obamacare enrollment, the agency said.

(Reporting by Amina NiasseEditing by Bill Berkrot)

((amina.niasse@thomsonreuters.com;))

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10